GB202108170D0 - Theraputic inhibitors of GDF15 Signalling - Google Patents
Theraputic inhibitors of GDF15 SignallingInfo
- Publication number
- GB202108170D0 GB202108170D0 GBGB2108170.8A GB202108170A GB202108170D0 GB 202108170 D0 GB202108170 D0 GB 202108170D0 GB 202108170 A GB202108170 A GB 202108170A GB 202108170 D0 GB202108170 D0 GB 202108170D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- theraputic
- gdf15
- signalling
- inhibitors
- theraputic inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2108170.8A GB202108170D0 (en) | 2021-06-08 | 2021-06-08 | Theraputic inhibitors of GDF15 Signalling |
AU2022251923A AU2022251923A1 (en) | 2021-03-31 | 2022-03-31 | Therapeutic inhibitors of gdf15 signalling |
IL307382A IL307382A (en) | 2021-03-31 | 2022-03-31 | Therapeutic inhibitors of gdf15 signalling |
KR1020237037287A KR20230165285A (en) | 2021-03-31 | 2022-03-31 | Therapeutic inhibitors of GDF15 signaling |
CA3215737A CA3215737A1 (en) | 2021-03-31 | 2022-03-31 | Therapeutic inhibitors of gdf15 signalling |
JP2023560403A JP2024511853A (en) | 2021-03-31 | 2022-03-31 | Therapeutic inhibitors of GDF15 signaling |
BR112023020152A BR112023020152A2 (en) | 2021-03-31 | 2022-03-31 | THERAPEUTIC INHIBITORS OF GDF15 SIGNALING |
EP22720935.0A EP4314071A1 (en) | 2021-03-31 | 2022-03-31 | Therapeutic inhibitors of gdf15 signalling |
PCT/EP2022/058669 WO2022207846A1 (en) | 2021-03-31 | 2022-03-31 | Therapeutic inhibitors of gdf15 signalling |
CN202280037901.0A CN117916262A (en) | 2021-03-31 | 2022-03-31 | Therapeutic inhibitors of GDF15 signaling |
CONC2023/0013791A CO2023013791A2 (en) | 2021-03-31 | 2023-10-19 | Therapeutic inhibitors of gdf15 signaling |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2108170.8A GB202108170D0 (en) | 2021-06-08 | 2021-06-08 | Theraputic inhibitors of GDF15 Signalling |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202108170D0 true GB202108170D0 (en) | 2021-07-21 |
Family
ID=76838735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2108170.8A Ceased GB202108170D0 (en) | 2021-03-31 | 2021-06-08 | Theraputic inhibitors of GDF15 Signalling |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN117916262A (en) |
GB (1) | GB202108170D0 (en) |
-
2021
- 2021-06-08 GB GBGB2108170.8A patent/GB202108170D0/en not_active Ceased
-
2022
- 2022-03-31 CN CN202280037901.0A patent/CN117916262A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN117916262A (en) | 2024-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4069212A4 (en) | Inhibitors of hif-2alpha | |
IL281939A (en) | Inhibitors of vap-1 | |
IL283592A (en) | Inhibitors of apol1 and methods of using same | |
IL287768A (en) | Kcnt1 inhibitors and methods of use | |
IL287751A (en) | Kcnt1 inhibitors and methods of use | |
ZA202006092B (en) | Imidazopiperazine inhibitors of transcription activating proteins | |
ZA202203770B (en) | Pharmaceutical combination of prmt5 inhibitors | |
IL287973A (en) | Acss2 inhibitors and methods of use thereof | |
GB202003778D0 (en) | Use of lactoferrin | |
GB202103594D0 (en) | Antagonist of PCSK9 | |
IL281815A (en) | Inhibitors of vap-1 | |
IL284434A (en) | Inhibitors of fibroblast activation protein | |
IL288851A (en) | Heteroaromatic inhibitors of astacin proteinases | |
IL285867A (en) | Antisense oligomers for treatment of conditions and diseases | |
IL276312A (en) | Use of alkoxypyrazoles as nitrification inhibitors | |
IL286149A (en) | Caspase inhibitors and methods of use thereof | |
GB202108170D0 (en) | Theraputic inhibitors of GDF15 Signalling | |
PL3722401T3 (en) | Gel sanitary agent for biofilm inhibition | |
IL307382A (en) | Therapeutic inhibitors of gdf15 signalling | |
GB202107331D0 (en) | Therapeutic inhibitors of GDF15 signalling | |
GB202104556D0 (en) | Therapeutic inhibitors of GDF15 signalling | |
ZA202200268B (en) | Combination therapy of gpr119 agonists and dpp-4 inhibitors | |
IL283295A (en) | Inhibitors of gli1 as therapeutic agents | |
EP3968994C0 (en) | Abhd12 inhibitors and methods of making and using same | |
GB201907305D0 (en) | Treatment of conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |